Soluble B-cell activation marker of sCD27 and sCD30 and future risk of B-cell lymphomas: A nested case-control study and meta-analyses

Fatemeh Saberi Hosnijeh,Lützen Portengen,Florentin Späth,Ingvar A. Bergdahl,Beatrice Melin,Amalia Mattiello,Giovanna Masala,Carlotta Sacerdote,Alessio Naccarati,Vittorio Krogh,Rosario Tumino,Marc Chadeau-Hyam,Paolo Vineis,Roel Vermeulen

Soluble B-cell activation marker of sCD27 and sCD30 and future risk of B-cell lymphomas: A nested case-control study and meta-analyses

2016

Fatemeh Saberi Hosnijeh
Lützen Portengen
Florentin Späth
Ingvar A. Bergdahl
Beatrice Melin
Amalia Mattiello
Giovanna Masala
Carlotta Sacerdote
Alessio Naccarati
Vittorio Krogh
Rosario Tumino
Marc Chadeau-Hyam
Paolo Vineis
Roel Vermeulen

Pre-diagnostic serum/plasma concentrations of B-cell activation markers have been associated with future risk of B-cell lymphomas (BCL) in HIV-infected patients and in the general population. Curre ...

Keywords:

Prospective cohort study
Lymphoma
Cancer research
Case-control study
Biomarker (medicine)
Population
Nested case-control study
Odds ratio
B cell
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations